{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T11:35:25Z","timestamp":1786448125745,"version":"build-2736575974"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82220108016"],"award-info":[{"award-number":["82220108016"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1038\/s41433-026-04574-2","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T07:01:48Z","timestamp":1780038108000},"page":"1889-1898","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Causal relationship between aspirin use and age-related macular degeneration"],"prefix":"10.1038","volume":"40","author":[{"given":"Juanhua","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenggong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongsui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijun","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijun","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8277-0767","authenticated-orcid":false,"given":"Xuri","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"4574_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41572-021-00265-2","volume":"7","author":"M Fleckenstein","year":"2021","unstructured":"Fleckenstein M, Keenan TDL, Guymer RH, Chakravarthy U, Schmitz-Valckenberg S, Klaver CC, et al. Age-related macular degeneration. Nat Rev Dis Prim. 2021;7:31.","journal-title":"Nat Rev Dis Prim"},{"key":"4574_CR2","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/S0140-6736(22)02609-5","volume":"401","author":"RH Guymer","year":"2023","unstructured":"Guymer RH, Campbell TG. Age-related macular degeneration. Lancet. 2023;401:1459\u201372.","journal-title":"Lancet"},{"key":"4574_CR3","first-page":"513","volume":"117","author":"A Stahl","year":"2020","unstructured":"Stahl A. The diagnosis and treatment of age-related macular degeneration. Dtsch \u00c4rztebl Int. 2020;117:513\u201320.","journal-title":"Dtsch \u00c4rztebl Int"},{"key":"4574_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/09286586.2022.2059812","volume":"30","author":"X Han","year":"2023","unstructured":"Han X, Chen Y, Gordon I, Safi S, Lingham G, Evans J, et al. A systematic review of clinical practice guidelines for age-related macular degeneration. Ophthalmic Epidemiol. 2023;30:213\u201320.","journal-title":"Ophthalmic Epidemiol"},{"key":"4574_CR5","doi-asserted-by":"crossref","unstructured":"Ricci F, Bandello F, Navarra P, Staurenghi G, Stumpp M, Zarbin M. Neovascular age-related macular degeneration: therapeutic management and new-upcoming approaches. Int J Mol Sci. 2020;21.","DOI":"10.3390\/ijms21218242"},{"key":"4574_CR6","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1001\/jamaophthalmol.2018.1544","volume":"136","author":"FG Holz","year":"2018","unstructured":"Holz FG, Sadda SR, Busbee B, Chew EY, Mitchell P, Tufail A, et al. Efficacy and safety of Lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and Spectri Phase 3 randomized clinical trials. JAMA Ophthalmol. 2018;136:666\u201377.","journal-title":"JAMA Ophthalmol"},{"key":"4574_CR7","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/S0140-6736(23)01520-9","volume":"402","author":"JS Heier","year":"2023","unstructured":"Heier JS, Lad EM, Holz FG, Rosenfeld PJ, Guymer RH, Boyer D, et al. Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials. Lancet. 2023;402:1434\u201348.","journal-title":"Lancet"},{"key":"4574_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vph.2018.10.008","volume":"113","author":"MR Montinari","year":"2019","unstructured":"Montinari MR, Minelli S, De Caterina R. The first 3500 years of aspirin history from its roots - A concise summary. Vasc Pharm. 2019;113:1\u20138.","journal-title":"Vasc Pharm"},{"key":"4574_CR9","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0049-3848(03)00379-7","volume":"110","author":"JR Vane","year":"2003","unstructured":"Vane JR, Botting RM. The mechanism of action of aspirin. Thromb Res. 2003;110:255\u20138.","journal-title":"Thromb Res"},{"key":"4574_CR10","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","volume":"373","author":"C Baigent","year":"2009","unstructured":"Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373:1849\u201360.","journal-title":"Lancet"},{"key":"4574_CR11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ijcard.2017.03.046","volume":"241","author":"AC Fanaroff","year":"2017","unstructured":"Fanaroff AC, Hasselblad V, Roe MT, Bhatt DL, James SK, Steg PG, et al. Antithrombotic agents for secondary prevention after acute coronary syndromes: A systematic review and network meta-analysis. Int J Cardiol. 2017;241:87\u201396.","journal-title":"Int J Cardiol"},{"key":"4574_CR12","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1472-8206.2009.00769.x","volume":"24","author":"M Li\u00e8vre","year":"2010","unstructured":"Li\u00e8vre M, Cucherat M. Aspirin in the secondary prevention of cardiovascular disease: an update of the APTC meta-analysis. Fundam Clin Pharm. 2010;24:385\u201391.","journal-title":"Fundam Clin Pharm"},{"key":"4574_CR13","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/bjh.14520","volume":"177","author":"MJR Desborough","year":"2017","unstructured":"Desborough MJR, Keeling DM. The aspirin story - from willow to wonder drug. Br J Haematol. 2017;177:674\u201383.","journal-title":"Br J Haematol"},{"key":"4574_CR14","doi-asserted-by":"crossref","unstructured":"Anderson DH, Radeke MJ, Gallo NB, Chapin EA, Johnson PT, Curletti CR, et al. The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res. 2010;29.","DOI":"10.1016\/j.preteyeres.2009.11.003"},{"key":"4574_CR15","volume":"6","author":"N Tzoumas","year":"2023","unstructured":"Tzoumas N, Riding G, Williams MA, Steel DH. Complement inhibitors for age-related macular degeneration. Cochrane Database Syst Rev. 2023;6:CD009300.","journal-title":"Cochrane Database Syst Rev"},{"key":"4574_CR16","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s40266-021-00885-z","volume":"38","author":"X Xu","year":"2021","unstructured":"Xu X, Ritz B, Coleman AL, Liew Z, Deapen D, Lee E, et al. Non-steroidal anti-inflammatory drug use and risk of age-related macular degeneration in the California Teachers Study. Drugs Aging. 2021;38:817\u201328.","journal-title":"Drugs Aging"},{"key":"4574_CR17","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.jfma.2023.09.014","volume":"123","author":"T-M Yang","year":"2024","unstructured":"Yang T-M, Huang W-L, Yang C-H, Yang C-M, Ho T-C, Chen T-C, et al. Association between non-steroidal anti-inflammatory drug use and development of age-related macular degeneration-A 10-year retrospective cohort study. J Formos Med Assoc. 2024;123:467\u201377.","journal-title":"J Formos Med Assoc"},{"key":"4574_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ajo.2018.01.012","volume":"188","author":"BS Modjtahedi","year":"2018","unstructured":"Modjtahedi BS, Fong DS, Jorgenson E, Van Den Eeden SK, Quinn V, Slezak JM. The relationship between nonsteroidal anti-inflammatory drug use and age-related macular degeneration. Am J Ophthalmol. 2018;188:111\u201322.","journal-title":"Am J Ophthalmol"},{"key":"4574_CR19","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1001\/archopht.119.8.1143","volume":"119","author":"WG Christen","year":"2001","unstructured":"Christen WG, Glynn RJ, Ajani UA, Schaumberg DA, Chew EY, Buring JE, et al. Age-related maculopathy in a randomized trial of low-dose aspirin among US physicians. Arch Ophthalmol. 2001;119:1143\u20139.","journal-title":"Arch Ophthalmol"},{"key":"4574_CR20","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/pds.5145","volume":"30","author":"W-JA Lee","year":"2021","unstructured":"Lee W-JA, Yang Y-HK, Cheng C-L. Risk of age-related macular degeneration in aspirin users and non-aspirin users: A population-based cohort study in Taiwan. Pharmacoepidemiol Drug Saf. 2021;30:178\u201388.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"4574_CR21","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ophtha.2011.06.025","volume":"119","author":"PTVM de Jong","year":"2012","unstructured":"de Jong PTVM, Chakravarthy U, Rahu M, Seland J, Soubrane G, Topouzis F, et al. Associations between aspirin use and aging macula disorder: the European Eye Study. Ophthalmology. 2012;119:112\u20138.","journal-title":"Ophthalmology"},{"key":"4574_CR22","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/S0161-6420(86)33540-1","volume":"93","author":"F el Baba","year":"1986","unstructured":"el Baba F, Jarrett WH, Harbin TS, Fine SL, Michels RG, Schachat AP, et al. Massive hemorrhage complicating age-related macular degeneration Clinicopathologic correlation role of anticoagulants.Ophthalmolgy. 1986;93:1581\u201392.","journal-title":"Ophthalmolgy"},{"key":"4574_CR23","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1097\/IAE.0b013e3181e2266d","volume":"30","author":"DF Kiernan","year":"2010","unstructured":"Kiernan DF, Hariprasad SM, Rusu IM, Mehta SV, Mieler WF, Jager RD. Epidemiology of the association between anticoagulants and intraocular hemorrhage in patients with neovascular age-related macular degeneration. Retina. 2010;30:1573\u20138.","journal-title":"Retina"},{"key":"4574_CR24","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1001\/jama.2012.65406","volume":"308","author":"BEK Klein","year":"2012","unstructured":"Klein BEK, Howard KP, Gangnon RE, Dreyer JO, Lee KE, Klein R. Long-term use of aspirin and age-related macular degeneration. JAMA. 2012;308:2469\u201378.","journal-title":"JAMA"},{"key":"4574_CR25","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1001\/jamainternmed.2013.1583","volume":"173","author":"G Liew","year":"2013","unstructured":"Liew G, Mitchell P, Wong TY, Rochtchina E, Wang JJ. The association of aspirin use with age-related macular degeneration. JAMA Intern Med. 2013;173:258\u201364.","journal-title":"JAMA Intern Med"},{"key":"4574_CR26","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1016\/j.ophtha.2009.05.031","volume":"116","author":"WG Christen","year":"2009","unstructured":"Christen WG, Glynn RJ, Chew EY, Buring JE. Low-dose aspirin and medical record-confirmed age-related macular degeneration in a randomized trial of women. Ophthalmology. 2009;116:2386\u201392.","journal-title":"Ophthalmology"},{"key":"4574_CR27","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ajo.2018.01.003","volume":"187","author":"GHS Buitendijk","year":"2018","unstructured":"Buitendijk GHS, Schauwvlieghe A-SME, Vingerling JR, Schlingemann RO, Klaver CCW. Antiplatelet and anticoagulant drugs do not affect visual outcome in neovascular age-related macular degeneration in the BRAMD Trial. Am J Ophthalmol. 2018;187:130\u20137.","journal-title":"Am J Ophthalmol"},{"key":"4574_CR28","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.ophtha.2018.09.014","volume":"126","author":"TH Rim","year":"2019","unstructured":"Rim TH, Yoo TK, Kwak J, Lee JS, Kim SH, Kim DW, et al. Long-term regular use of low-dose aspirin and neovascular age-related macular degeneration: National Sample Cohort 2010-2015. Ophthalmology. 2019;126:274\u201382.","journal-title":"Ophthalmology"},{"key":"4574_CR29","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/j.ophtha.2019.06.023","volume":"126","author":"TD Keenan","year":"2019","unstructured":"Keenan TD, Wiley HE, Agr\u00f3n E, Aronow ME, Christen WG, Clemons TE, et al. The association of aspirin use with age-related macular degeneration progression in the age-related eye disease studies: Age-Related Eye Disease Study 2 Report No. 20. Ophthalmology. 2019;126:1647\u201356.","journal-title":"Ophthalmology"},{"key":"4574_CR30","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1001\/jamaophthalmol.2024.1584","volume":"142","author":"LD Robman","year":"2024","unstructured":"Robman LD, Wolfe R, Woods RL, Thao LTP, Makeyeva GA, Hodgson LAB, et al. Effect of low-dose aspirin on the course of age-related macular degeneration: a secondary analysis of the ASPREE randomized clinical trial. JAMA Ophthalmol. 2024;142:627\u201335.","journal-title":"JAMA Ophthalmol"},{"key":"4574_CR31","doi-asserted-by":"crossref","unstructured":"Smith GD, Ebrahim S. \u2018Mendelian randomization\u2019: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32.","DOI":"10.1093\/ije\/dyg070"},{"key":"4574_CR32","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1001\/jama.2009.812","volume":"301","author":"G Thanassoulis","year":"2009","unstructured":"Thanassoulis G, O\u2019Donnell CJ. Mendelian randomization: nature\u2019s randomized trial in the post-genome era. JAMA. 2009;301:2386\u20138.","journal-title":"JAMA"},{"key":"4574_CR33","doi-asserted-by":"crossref","unstructured":"Julian TH, Cooper-Knock J, MacGregor S, Guo H, Aslam T, Sanderson E, et al. Phenome-wide Mendelian randomisation analysis identifies causal factors for age-related macular degeneration. Elife. 2023;12.","DOI":"10.7554\/eLife.82546"},{"key":"4574_CR34","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s10654-019-00598-z","volume":"35","author":"X Han","year":"2020","unstructured":"Han X, Ong J-S, An J, Hewitt AW, Gharahkhani P, MacGregor S. Using Mendelian randomization to evaluate the causal relationship between serum C-reactive protein levels and age-related macular degeneration. Eur J Epidemiol. 2020;35:139\u201346.","journal-title":"Eur J Epidemiol"},{"key":"4574_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112678","volume":"139","author":"T Wang","year":"2024","unstructured":"Wang T, Chen J, Wang J, Zhang Y, Mao W, Yi Q. 91 Circulating inflammatory proteins and the risk of age-related macular degeneration: A bidirectional Mendelian randomization study. Int Immunopharmacol. 2024;139:112678.","journal-title":"Int Immunopharmacol"},{"key":"4574_CR36","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12944-024-02197-8","volume":"23","author":"G Han","year":"2024","unstructured":"Han G, Wei P, He M, Jia L, Su Q, Yang X, et al. Role of plasma fatty acid in age-related macular degeneration: insights from a Mendelian randomization analysis. Lipids Health Dis. 2024;23:206.","journal-title":"Lipids Health Dis"},{"key":"4574_CR37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12263-023-00730-5","volume":"18","author":"F-F Li","year":"2023","unstructured":"Li F-F, Wang Y, Chen L, Chen C, Chen Q, Xiang L, et al. Causal effects of serum lipid biomarkers on early age-related macular degeneration using Mendelian randomization. Genes Nutr. 2023;18:11.","journal-title":"Genes Nutr"},{"key":"4574_CR38","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/ije\/dyaa178","volume":"50","author":"X Han","year":"2021","unstructured":"Han X, Ong J-S, Hewitt AW, Gharahkhani P, MacGregor S. The effects of eight serum lipid biomarkers on age-related macular degeneration risk: a Mendelian randomization study. Int J Epidemiol. 2021;50:325\u201336.","journal-title":"Int J Epidemiol"},{"key":"4574_CR39","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1001\/jamaophthalmol.2021.4601","volume":"139","author":"V Kuan","year":"2021","unstructured":"Kuan V, Warwick A, Hingorani A, Tufail A, Cipriani V, Burgess S, et al. Association of Smoking, Alcohol Consumption, Blood Pressure, Body Mass Index, and glycemic risk factors with age-related macular degeneration: A Mendelian randomization study. JAMA Ophthalmol. 2021;139:1299\u2013306.","journal-title":"JAMA Ophthalmol"},{"key":"4574_CR40","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1136\/gutjnl-2023-330784","volume":"73","author":"L Chen","year":"2024","unstructured":"Chen L, Qiu W, Sun X, Gao M, Zhao Y, Li M, et al. Novel insights into causal effects of serum lipids and lipid-modifying targets on cholelithiasis. Gut. 2024;73:521\u201332.","journal-title":"Gut"},{"key":"4574_CR41","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.2337\/db19-1134","volume":"69","author":"YC Klimentidis","year":"2020","unstructured":"Klimentidis YC, Arora A, Newell M, Zhou J, Ordovas JM, Renquist BJ, et al. Phenotypic and genetic characterization of lower LDL cholesterol and increased Type 2 Diabetes risk in the UK Biobank. Diabetes. 2020;69:2194\u2013205.","journal-title":"Diabetes"},{"key":"4574_CR42","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki MI, Karjalainen J, Palta P, Sipil\u00e4 TP, Kristiansson K, Donner KM, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613:508\u201318.","journal-title":"Nature"},{"key":"4574_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-020-00760-7","volume":"13","author":"TW Winkler","year":"2020","unstructured":"Winkler TW, Grassmann F, Brandl C, Kiel C, G\u00fcnther F, Strunz T, et al. Genome-wide association meta-analysis for early age-related macular degeneration highlights novel loci and insights for advanced disease. BMC Med Genomics. 2020;13:120.","journal-title":"BMC Med Genomics"},{"key":"4574_CR44","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1001\/jama.2017.17219","volume":"318","author":"CA Emdin","year":"2017","unstructured":"Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. JAMA. 2017;318:1925\u20136.","journal-title":"JAMA"},{"key":"4574_CR45","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40","author":"S Burgess","year":"2011","unstructured":"Burgess S, Thompson SG. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40:755\u201364.","journal-title":"Int J Epidemiol"},{"key":"4574_CR46","doi-asserted-by":"publisher","first-page":"e0120758","DOI":"10.1371\/journal.pone.0120758","volume":"10","author":"H Shim","year":"2015","unstructured":"Shim H, Chasman DI, Smith JD, Mora S, Ridker PM, Nickerson DA, et al. A multivariate genome-wide association analysis of 10 LDL subfractions, and their response to statin treatment, in 1868 Caucasians. PLoS One. 2015;10:e0120758.","journal-title":"PLoS One"},{"key":"4574_CR47","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1167\/iovs.64.13.4","volume":"64","author":"J Dai","year":"2023","unstructured":"Dai J, Suo L, Xian H, Pan Z, Zhang C. Investigating the impact of Sun\/UV protection and ease of skin tanning on the risk of Pseudoexfoliation Glaucoma: A Mendelian randomization study. Invest Ophthalmol Vis Sci. 2023;64:4.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4574_CR48","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA, et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement. JAMA. 2021;326:1614\u201321.","journal-title":"JAMA"},{"key":"4574_CR49","doi-asserted-by":"crossref","unstructured":"Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7.","DOI":"10.7554\/eLife.34408"},{"key":"4574_CR50","doi-asserted-by":"publisher","first-page":"4841","DOI":"10.1002\/alz.14049","volume":"20","author":"Y Liu","year":"2024","unstructured":"Liu Y, Xiao X, Yang Y, Yao R, Yang Q, Zhu Y, et al. The risk of Alzheimer\u2019s disease and cognitive impairment characteristics in eight mental disorders: A UK Biobank observational study and Mendelian randomization analysis. Alzheimer's Dement. 2024;20:4841\u201353.","journal-title":"Alzheimer's Dement"},{"key":"4574_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.938201","volume":"9","author":"N Gao","year":"2022","unstructured":"Gao N, Ni M, Song J, Kong M, Wei D, Dong A. Causal relationship between tea intake and cardiovascular diseases: A Mendelian randomization study. Front Nutr. 2022;9:938201.","journal-title":"Front Nutr"},{"key":"4574_CR52","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1681\/ASN.2020121760","volume":"32","author":"A Tin","year":"2021","unstructured":"Tin A, K\u00f6ttgen A. Mendelian randomization analysis as a tool to gain insights into causes of diseases: a primer. J Am Soc Nephrol. 2021;32:2400\u20137.","journal-title":"J Am Soc Nephrol"},{"key":"4574_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1179656","volume":"14","author":"Y Gao","year":"2023","unstructured":"Gao Y, Fan Z-R, Shi F-Y. Hypothyroidism and rheumatoid arthritis: a two-sample Mendelian randomization study. Front Endocrinol. 2023;14:1179656.","journal-title":"Front Endocrinol"},{"key":"4574_CR54","doi-asserted-by":"crossref","unstructured":"Thompson JR, Minelli C, Del Greco MF, Mendelian randomization using public data from Genetic Consortia. Int J Biostat. 2016;12.","DOI":"10.1515\/ijb-2015-0074"},{"key":"4574_CR55","doi-asserted-by":"publisher","first-page":"13371","DOI":"10.1073\/pnas.222543099","volume":"99","author":"TD Warner","year":"2002","unstructured":"Warner TD, Mitchell JA. Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?. Proc Natl Acad Sci USA. 2002;99:13371\u20133.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4574_CR56","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s11883-022-01037-3","volume":"24","author":"L Ferhatbegovi\u0107","year":"2022","unstructured":"Ferhatbegovi\u0107 L, Mr\u0161i\u0107 D, Ku\u0161ljugi\u0107 S, Pojski\u0107 B. LDL-C: The only causal risk factor for ASCVD. Why is it still overlooked and underestimated?. Curr Atheroscler Rep. 2022;24:635\u201342.","journal-title":"Curr Atheroscler Rep"},{"key":"4574_CR57","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0014-2999(99)00246-0","volume":"372","author":"O Al Rayyes","year":"1999","unstructured":"Al Rayyes O, Ahr\u00e9n B, Flor\u00e9n CH. Enhancement of low density lipoprotein catabolism by non-steroidal anti-inflammatory drugs in cultured HepG2 cells. Eur J Pharm. 1999;372:311\u20138.","journal-title":"Eur J Pharm"},{"key":"4574_CR58","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/00041433-199706000-00006","volume":"8","author":"K Schoonjans","year":"1997","unstructured":"Schoonjans K, Martin G, Staels B, Auwerx J. Peroxisome proliferator-activated receptors, orphans with ligands and functions. Curr Opin Lipido. 1997;8:159\u201366.","journal-title":"Curr Opin Lipido"},{"key":"4574_CR59","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.preteyeres.2004.05.001","volume":"23","author":"TH Margrain","year":"2004","unstructured":"Margrain TH, Boulton M, Marshall J, Sliney DH. Do blue light filters confer protection against age-related macular degeneration?. Prog Retin Eye Res. 2004;23:523\u201331.","journal-title":"Prog Retin Eye Res"},{"key":"4574_CR60","first-page":"1306","volume":"12","author":"N Tserentsoodol","year":"2006","unstructured":"Tserentsoodol N, Sztein J, Campos M, Gordiyenko NV, Fariss RN, Lee JW, et al. Uptake of cholesterol by the retina occurs primarily via a low density lipoprotein receptor-mediated process. Mol Vis. 2006;12:1306\u201318.","journal-title":"Mol Vis"},{"key":"4574_CR61","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.ajpath.2011.10.015","volume":"180","author":"L Yin","year":"2012","unstructured":"Yin L, Shi Y, Liu X, Zhang H, Gong Y, Gu Q, et al. A rat model for studying the biological effects of circulating LDL in the choriocapillaris-BrM-RPE complex. Am J Pathol. 2012;180:541\u20139.","journal-title":"Am J Pathol"},{"key":"4574_CR62","doi-asserted-by":"publisher","first-page":"H76","DOI":"10.1152\/ajpheart.00708.2019","volume":"319","author":"A Muscella","year":"2020","unstructured":"Muscella A, Stef\u00e0no E, Marsigliante S. The effects of exercise training on lipid metabolism and coronary heart disease. Am J Physiol Heart Circ Physiol. 2020;319:H76\u2013H88.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"4574_CR63","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/j.jnutbio.2015.08.008","volume":"26","author":"K-H Park","year":"2015","unstructured":"Park K-H, Kim J-Y, Choi I, Kim J-R, Cho K-H. \u03c9-6 (18:2) and \u03c9-3 (18:3) fatty acids in reconstituted high-density lipoproteins show different functionality of anti-atherosclerotic properties and embryo toxicity. J Nutr Biochem. 2015;26:1613\u201321.","journal-title":"J Nutr Biochem"},{"key":"4574_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-018-0941-9","volume":"18","author":"J-H Baek","year":"2018","unstructured":"Baek J-H, Lim D, Park KH, Chae J-B, Jang H, Lee J, et al. Quantitative proteomic analysis of aqueous humor from patients with drusen and reticular pseudodrusen in age-related macular degeneration. BMC Ophthalmol. 2018;18:289.","journal-title":"BMC Ophthalmol"},{"key":"4574_CR65","doi-asserted-by":"publisher","first-page":"18277","DOI":"10.1073\/pnas.1109703108","volume":"108","author":"LV Johnson","year":"2011","unstructured":"Johnson LV, Forest DL, Banna CD, Radeke CM, Maloney MA, Hu J, et al. Cell culture model that mimics drusen formation and triggers complement activation associated with age-related macular degeneration. Proc Natl Acad Sci USA. 2011;108:18277\u201382.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4574_CR66","doi-asserted-by":"publisher","first-page":"14682","DOI":"10.1073\/pnas.222551899","volume":"99","author":"JW Crabb","year":"2002","unstructured":"Crabb JW, Miyagi M, Gu X, Shadrach K, West KA, Sakaguchi H, et al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci USA. 2002;99:14682\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4574_CR67","doi-asserted-by":"publisher","first-page":"e2749","DOI":"10.1210\/clinem\/dgab095","volume":"106","author":"LT Nordestgaard","year":"2021","unstructured":"Nordestgaard LT, Tybj\u00e6rg-Hansen A, Frikke-Schmidt R, Nordestgaard BG. Elevated Apolipoprotein A1 and HDL Cholesterol Associated with Age-related Macular Degeneration: 2 Population Cohorts. J Clin Endocrinol Metab. 2021;106:e2749\u2013e58.","journal-title":"J Clin Endocrinol Metab"},{"key":"4574_CR68","doi-asserted-by":"crossref","unstructured":"Lee Y, Seo JH. The potential causal association of Apolipoprotein A and B and age-related macular degeneration: A Mendelian Randomisation Study. Biomedicines. 2024;12.","DOI":"10.3390\/biomedicines12122828"},{"key":"4574_CR69","doi-asserted-by":"publisher","first-page":"274629","DOI":"10.1155\/2011\/274629","volume":"2011","author":"HB G","year":"2011","unstructured":"G HB, Rao VS, Kakkar VV. Friend turns foe: transformation of anti-inflammatory HDL to Proinflammatory HDL during acute-phase response. Cholesterol. 2011;2011:274629.","journal-title":"Cholesterol"},{"key":"4574_CR70","doi-asserted-by":"publisher","first-page":"78","DOI":"10.2174\/1874091X01206010078","volume":"6","author":"E Eren","year":"2012","unstructured":"Eren E, Yilmaz N, Aydin O. High density Lipoprotein and its Dysfunction. Open Biochem J. 2012;6:78\u201393.","journal-title":"Open Biochem J"},{"key":"4574_CR71","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.preteyeres.2014.03.002","volume":"41","author":"IA Pikuleva","year":"2014","unstructured":"Pikuleva IA, Curcio CA. Cholesterol in the retina: the best is yet to come. Prog Retin Eye Res. 2014;41:64\u201389.","journal-title":"Prog Retin Eye Res"},{"key":"4574_CR72","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.preteyeres.2017.03.002","volume":"60","author":"S Datta","year":"2017","unstructured":"Datta S, Cano M, Ebrahimi K, Wang L, Handa JT. The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD. Prog Retin Eye Res. 2017;60:201\u201318.","journal-title":"Prog Retin Eye Res"},{"key":"4574_CR73","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.013470","volume":"9","author":"X Jiang","year":"2020","unstructured":"Jiang X, Liu X, Liu X, Wu X, Jose PA, Liu M, et al. Low-dose Aspirin treatment attenuates male rat salt-sensitive hypertension via Platelet Cyclooxygenase 1 and Complement Cascade Pathway. J Am Heart Assoc. 2020;9:e013470.","journal-title":"J Am Heart Assoc"},{"key":"4574_CR74","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S0140-6736(24)01308-4","volume":"404","author":"BG Nordestgaard","year":"2024","unstructured":"Nordestgaard BG, Langsted A. Lipoprotein(a) and cardiovascular disease. Lancet. 2024;404:1255\u201364.","journal-title":"Lancet"},{"key":"4574_CR75","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.tem.2023.05.002","volume":"34","author":"LG Yang","year":"2023","unstructured":"Yang LG, March ZM, Stephenson RA, Narayan PS. Apolipoprotein E in lipid metabolism and neurodegenerative disease. Trends Endocrinol Metab. 2023;34:430\u201345.","journal-title":"Trends Endocrinol Metab"},{"key":"4574_CR76","doi-asserted-by":"publisher","first-page":"e067731","DOI":"10.1136\/bmj-2021-067731","volume":"376","author":"A Hodkinson","year":"2022","unstructured":"Hodkinson A, Tsimpida D, Kontopantelis E, Rutter MK, Mamas MA, Panagioti M. Comparative effectiveness of statins on non-high density lipoprotein cholesterol in people with diabetes and at risk of cardiovascular disease: systematic review and network meta-analysis. BMJ. 2022;376:e067731.","journal-title":"BMJ"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04574-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04574-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04574-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T11:02:54Z","timestamp":1786446174000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04574-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":76,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["4574"],"URL":"https:\/\/doi.org\/10.1038\/s41433-026-04574-2","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"27 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}